University of Washington
Seattle, Washington, 98195, United States
Location status: Recruiting
Location contact
David E. Reed
CONTACT
NCT Number: NCT06219408
The goal of this clinical trial is to evaluate the feasibility, acceptability, appropriateness, and retention of patient participants of a CIH Stepped Care approach for co-occurring chronic pain and PTSD vs. treatment as usual in two primary care settings (one rural and one urban).
Researchers will compare CIH Stepped Care to treatment as usual.
Participants will complete assessments at baseline, 3-months, 6-months, and 9-months, and those in the CIH Stepped Care condition will participate in the intervention while also completed assessments every 2-weeks, which helps determine their treatment.
We hypothesize that, at 6-months, CIH Stepped Care will be feasible, acceptable, and appropriate (defined by an average of 4/5 on each measure) to patients and clinic employees and result in at least 70% of individuals be retained in each condition (n=21 per condition).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Seattle, Washington, 98195, United States
Location status: Recruiting
David E. Reed
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In order to be eligible to participate in this study, clinic employees must meet all of the following criteria:
In order to be eligible to participate in this study, patients must meet all of the following criteria:
4.2 Exclusion Criteria
There are no exclusion criteria for clinic employees.
Patients who meet any of the following criteria will be excluded from participation in this study:
CIH Stepped Care is a stepped approach to care delivered by a health coach (e.g., psychologist-in-training or clinical social worker) in-person or remotely (individual person sessions). It is a mindfulness-based and meaning-based stepped care approach for treating co-occurring chronic pain and PTSD that will begin with less intensive treatment (e.g., psychoeducation) and, based on patient response and preference, will be "stepped up" to more intensive treatment when appropriate.
Time frame: 6-months
Feasibility of intervention; 1-5; higher scores indicate greater feasibility
Time frame: 6-months
Acceptability of Intervention; 1-5; higher scores indicate greater acceptability
Time frame: 6-months
Appropriateness of Intervention; 1-5; higher scores indicate greater appropriateness
Time frame: 6-months
Percentage of Participants Retained in Intervention Arm
Time frame: Baseline, 3-, 6-, and 9-months
PTSD symptoms; 0-80; higher scores indicate more severe PTSD symptoms
Time frame: Baseline, 3-, 6-, and 9-months
Pain interference; 0-100; higher scores indicate worse pain interference
Time frame: Measurement-based care (every 2 weeks for those in CIH Stepped Care)
Pain severity and interference; 0-10; higher scores indicate more pain severity and interference
Time frame: Baseline, 3-, 6-, and 9-Months
Happiness and Life Satisfaction; 0-10; higher scores indicate greater happiness and life satisfaction
Time frame: Measurement-based care
Meaning and Purpose (every 2 weeks for those in CIH Stepped Care); 0-10; higher scores indicate greater meaning and purpose
Time frame: Baseline, 3-, 6-, and 9-months
Cognitive re-appraisal; 3-21; higher scores indicate greater cognitive re-appraisal
Time frame: Baseline, 3-, 6-, and 9-months
Decentering; 0-10; higher scores indicate higher decentering
Time frame: Baseline, 3-, 6-, and 9-months
Meaning in Life; 1-7; higher scores indicate more meaning in life
Time frame: Baseline, 3-, 6-, and 9-months
Existential Anxiety; 1-5; higher scores indicate more existential anxiety
Time frame: Baseline, 3-, 6-, and 9-months
Mindfulness; 24-120; higher scores indicate more mindfulness
Time frame: 3-, 6-, and 9-months
Suicidality; 6 items; risk levels of high, moderate, low/no risk are determined
Time frame: Baseline, 3-, 6-, and 9-Months
Anxiety; 0-21; higher scores indicate more severe anxiety symptoms
Time frame: Baseline, 3-, 6-, and 9-Months
Depression; 0-27; higher scores indicate more severe depression symptoms
Time frame: Baseline, 3-, 6-, and 9-Months
Physical Health; 0-100 T-scores; higher scores indicate greater physical health function
Time frame: 3- and 6-months
Therapeutic Alliance; 1-7; higher scores indicate greater working patient-provider therapeutic alliance
Time frame: 6-months
1-item on why participant discontinued study
Time frame: 6-months
Treatment fidelity; percentage of items completed; greater percentage indicates higher fidelity
Time frame: Measurement-based care (every 2 weeks for those in CIH Stepped Care)
PTSD Symptoms; 0-80; higher scores indicate higher PTSD symptom severity
Time frame: 6-months
Adherence (defined as completing over 50% of the measurement-based care assessments that occur every 2 weeks and completing participant-health coach measurement-based care contacts, where, for instance, treatment options would be discussed)
Time frame: Baseline, 3-, 6-, and 9-months
Medication use (name, dose, and frequency)
Time frame: Baseline, 3-, 6-, and 9-months
Healthcare use; frequency of different healthcare services used (e.g., primary care visits)
Time frame: Measurement-based care (every 2 weeks for those in CIH Stepped Care)
1-item asking patients in the CIH Stepped Care condition whether they would like to change treatments
Time frame: 3- and 6-months
Therapeutic Alliance; 1-7; higher scores indicate greater working patient-provider therapeutic alliance
Contact information is provided by the study sponsor or research team.
University of Washington
Other
A Pilot Randomized Controlled Trial of CIH Stepped Care for Co-occurring Chronic Pain and PTSD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05534126
Chronic Pain, Mental Disorders
Chicago, Illinois, United States
View Trial DetailsNCT02657317
Agnosia, Behavior
San Antonio, Texas, United States
View Trial DetailsNCT03418129
Brain Diseases, Brain Injuries
Durham, North Carolina, United States
View Trial DetailsNCT03247179
Acute Pain Due to Trauma, Chronic Pain
Pittsburgh, Pennsylvania, United States
View Trial Details